InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（1 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the full record of transactions filed by Heyman Tomas J., Director. Director active across 2 companies, notably Akero Therapeutics, Inc.. Cumulatively, 8 disclosures have been logged. Breakdown: 0 buy · 1 sell. Total volume traded: €178k. History available since 31 May 2023. The latest transaction was filed on 27 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Heyman Tomas J.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报8 总计
8,367 股0Common StockSEC:0000939767-26-000082:0
9,398 股Common StockSEC:0001193125-25-312134:0
9,398 股0Common StockSEC:0000950170-25-082307:0
9,812 股0Common StockSEC:0000939767-25-000092:0
4,544 股@ US$44.29100.0% 占其流量Common StockSEC:0000939767-25-000084:0
18,838 股0Common StockSEC:0000939767-24-000099:0
26,000 股@ US$25.04100.0% 占其流量Common StockSEC:0000950170-23-029231:0
18,176 股0Common StockSEC:0000939767-23-000065:0
8 条申报中的 8 条
About Heyman Tomas J.
Tomas J. Heyman is a Director at Akero Therapeutics, Inc. In this role, he contributes to the governance of the company and strategic decision-making. His expertise in the biopharmaceutical sector is essential for guiding Akero towards innovation and growth.
